„Grundgerüstwechsel”︁ (Scaffold‐Hopping) durch topologische Pharmakophorsuche: ein Beitrag zum virtuellen Screening

[1]  R. Bohacek,et al.  Modern computational chemistry and drug discovery: structure generating programs. , 1997, Current opinion in chemical biology.

[2]  David R. Liu,et al.  Das Hervorbringen neuer molekularer Funktionen: ein Lehrstück der Natur , 1999 .

[3]  C L Brooks,et al.  Do active site conformations of small ligands correspond to low free-energy solution structures? , 1998, Journal of computer-aided molecular design.

[4]  J. Gasteiger,et al.  Autocorrelation of Molecular Surface Properties for Modeling Corticosteroid Binding Globulin and Cytosolic Ah Receptor Activity by Neural Networks , 1995 .

[5]  P. Molenaar,et al.  Human vascular to cardiac tissue selectivity of L‐ and T‐type calcium channel antagonists , 1998, British journal of pharmacology.

[6]  G Schneider,et al.  Artificial neural networks for computer-based molecular design. , 1998, Progress in biophysics and molecular biology.

[7]  I. Kuntz,et al.  Molecular similarity based on DOCK-generated fingerprints. , 1996, Journal of medicinal chemistry.

[8]  D. D. Jones,et al.  Amino acid properties and side-chain orientation in proteins: a cross correlation appraoch. , 1975, Journal of theoretical biology.

[9]  G. Schneider,et al.  Peptide design by artificial neural networks and computer-based evolutionary search. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[11]  S. Ertel,et al.  Low-voltage-activated T-type Ca2+ channels. , 1997, Trends in pharmacological sciences.

[12]  S. Anzali,et al.  Endothelin antagonists: search for surrogates of methylendioxyphenyl by means of a Kohonen neural network. , 1998, Bioorganic & medicinal chemistry letters.

[13]  M C Nicklaus,et al.  Pharmacophores in drug design and discovery. , 1998, SAR and QSAR in environmental research.

[14]  David R. Liu,et al.  Generating New Molecular Function: A Lesson from Nature , 1999 .

[15]  Brown Rd,et al.  An Evaluation of Structural Descriptors and Clustering Methods for Use in Diversity Selection , 1998 .

[16]  M. Lazdunski,et al.  Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac, and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade. , 1987, European journal of pharmacology.

[17]  H. Matter,et al.  Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors. , 1997, Journal of medicinal chemistry.

[18]  J. Gasteiger,et al.  FROM ATOMS AND BONDS TO THREE-DIMENSIONAL ATOMIC COORDINATES : AUTOMATIC MODEL BUILDERS , 1993 .

[19]  M Karplus,et al.  Functionality map analysis of the active site cleft of human thrombin , 1996, J. Comput. Aided Mol. Des..